Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)

Market Cap	6.23B -45.2%
Revenue (ttm)	2.32B -10.3%
Net Income	152.57M -61.5%
EPS	0.66 -61.3%
Shares Out	n/a
PE Ratio	40.80
Forward PE	n/a
Dividend	1.00 (3.32%)
Ex-Dividend Date	Jun 17, 2026

Volume	314,708
Open	30.60
Previous Close	30.61
Day's Range	30.03 - 30.62
52-Week Range	27.60 - 56.88
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHA:688366

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,999
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688366

Financial Performance

In 2025, SHA:688366's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error